Abstract
Objective: To explore the patients’ views of the collection and use of patient-reported outcomes as part of routine care in patients with inflammatory arthritis. Methods: We conducted a qualitative focus group study based on interviews in each of the 5 geographical regions of Denmark. The analysis was based on content analysis. Four patient research partners were involved in the study. Results: In total, 32 adult patients (21 female) with rheumatoid arthritis (n = 21), psoriatic arthritis (n = 6), and axial spondyloarthritis (n = 5) participated. The mean age was 60 years (range 32–80 years). Five themes were derived from the analysis: 1) a need for information about why the data are collected, reflecting patients’ uncertainty as to whether the collection of patient-reported outcomes primarily served to monitor their own disease, to save money, or to gather data for research purposes; 2) inclusion of patient-reported outcomes in the consultation, encompassing patients’ expectations of active use of the patient-reported outcomes data during talks with rheumatologists or nurses; 3) reflections on how to respond to the patient-reported outcome measures (PROMs) to obtain high quality data, referring to patients’ concerns about how to respond “correctly” and about issues that could affect their responses; 4) addressing patient-reported outcomes to the individual's challenges, reflecting the need for a more individualized approach; and 5) possibilities for improvement in the use of patient-reported outcomes, referring to patients’ ideas for the future use of patient-reported outcomes. Conclusion: Information and dialogue regarding the purpose of patient-reported outcomes collection, how to respond to PROMs correctly, and inclusion of the patient-reported outcomes data in the consultation are of importance to patients with inflammatory arthritis who routinely complete patient-reported outcomes.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Arthritis Care & Research |
ISSN | 2151-464X |
DOI | |
Status | Udgivet - 1 sep. 2020 |